Described herein are pharmaceutical packaging units which protect against oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-delicate drugs, these methods such as a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister